Stereotactic radiotherapy for oligometastatic disease
Friday, 21 May 2027
Course directors:
- Marianne Guren
- Peter van Rossum
- Jonas Willman
Course aim:
Best practice of SBRT for oligometastatic disease
Learning objectives:
Learn how to select patients for treatment of oligometastatic disease, and how to choose a safe treatment regimen with good efficacy
Target audience
Radiation oncologists, medical physicists, dosimetrists
Scientific programme
The scientific programme is available here.
Pre-course Webinar
More information to be published soon.
Accreditation
Application for CME recognition will be submitted to the European Accreditation Council for Continuing Medical Education (EACCME), an institution of the European Union of Medical Specialists (UEMS). EACCME credits are recognised by the American Medical Association towards the Physician’s Recognition Award (PRA). Information on the status of the applications can be obtained from the ESTRO office.